MembersMerck Invests in Israeli Biotechnology

The German pharmaceutical company Merck, together with other international companies in the same line of business, plan to launch a fund that will invest 20 million euros ($24.6 million) in Israeli biotechnology over the next five years.

By Michael Selutin |
Photo: Nati Shohat/Flash90

Merck’s managing director, Stefan Oschmann, said in Israel: “The spirit that drives Israeli start-ups is unique and inspiring. We are proud to play an active part in this success...

Israel Today Membership

Become a Member

  • Read all member content

    Get exclusive in-depth reports from Israel.

  • Get exclusive in-depth reports from Israel

    Connect with Israel, right from your home.

  • Lift up the voice of truth and hope

    Support Jerusalem-based Zionist journalism.

Already a member? .